Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Physis; Rivista Internazionale Di Storia Della Scienza
|
January 1, 1992
[Not Available]
V Cappelletti, G Barsanti, R Mazzolini, et al.
Pediatrics
|
June 1, 1978
Private practice view of otitis media
R Schwartz, R G Barsanti, W J Rodriguez
Southern Medical Journal
|
April 1, 1982
Vulvovaginitis in prepubertal girls: the importance of group A Streptococcus
R H Schwartz, R L Wientzen, R G Barsanti
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
November 15, 1975
[In-vitro stimulation of mitochondrial RNA synthesis in the performance of thyroid hormones]
A Barletta, G Bove, G Barsanti, et al.
Ear, Nose, & Throat Journal
|
March 1, 1984
Acute otitis media secondary to ampicillin-resistant H. influenzae
R H Schwartz, W J Rodriguez, R G Barsanti, et al.
The Annals of Otology, Rhinology & Laryngology. Supplement
|
May 1, 1980
Trimethoprim-sulfamethoxazole in the treatment of otitis media secondary to ampicillin-resistant strains of Haemophilus influenzae
R Schwartz, W J Rodriguez, W Khan, et al.
Reviews of Infectious Diseases
|
March 1, 1982
Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae
R H Schwartz, W J Rodriguez, W N Khan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results
P Pacini, M Rinaldini, R Algeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients
G Bocci, R Danesi, A D Di Paolo, et al.
Lancet (London, England)
|
April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy
R Passalacqua, F Campione, C Caminiti, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Physis; Rivista Internazionale Di Storia Della Scienza
|
January 1, 1992
[Not Available]
V Cappelletti, G Barsanti, R Mazzolini, et al.
Pediatrics
|
June 1, 1978
Private practice view of otitis media
R Schwartz, R G Barsanti, W J Rodriguez
Southern Medical Journal
|
April 1, 1982
Vulvovaginitis in prepubertal girls: the importance of group A Streptococcus
R H Schwartz, R L Wientzen, R G Barsanti
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
November 15, 1975
[In-vitro stimulation of mitochondrial RNA synthesis in the performance of thyroid hormones]
A Barletta, G Bove, G Barsanti, et al.
Ear, Nose, & Throat Journal
|
March 1, 1984
Acute otitis media secondary to ampicillin-resistant H. influenzae
R H Schwartz, W J Rodriguez, R G Barsanti, et al.
The Annals of Otology, Rhinology & Laryngology. Supplement
|
May 1, 1980
Trimethoprim-sulfamethoxazole in the treatment of otitis media secondary to ampicillin-resistant strains of Haemophilus influenzae
R Schwartz, W J Rodriguez, W Khan, et al.
Reviews of Infectious Diseases
|
March 1, 1982
Trimethoprim-sulfamethoxazole in the treatment of otitis media caused by ampicillin-resistant strains of Haemophilus influenzae
R H Schwartz, W J Rodriguez, W N Khan, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 8, 2000
FEC (5-fluorouracil, epidoxorubicin and cyclophosphamide) versus EM (epidoxorubicin and mitomycin-C) with or without lonidamine as first-line treatment for advanced breast cancer. A multicentric randomised study. Final results
P Pacini, M Rinaldini, R Algeri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 24, 2000
Comparative pharmacokinetic analysis of 5-fluorouracil and its major metabolite 5-fluoro-5,6-dihydrouracil after conventional and reduced test dose in cancer patients
G Bocci, R Danesi, A D Di Paolo, et al.
Lancet (London, England)
|
April 28, 1999
Patients' opinions, feelings, and attitudes after a campaign to promote the Di Bella therapy
R Passalacqua, F Campione, C Caminiti, et al.
Page
of 1